Seino Yoshihiko, Ogawa Akio, Yamashita Teruyo, Fukushima Masato, Ogata Ken-ichi, Fukumoto Hiroko, Takano Teruo
The First Department of Internal Medicine, Nippon Medical School, 1-1-5 Sendagi, Tokyo, Japan.
Eur J Heart Fail. 2004 Mar 15;6(3):295-300. doi: 10.1016/j.ejheart.2003.12.009.
Measurement of brain natriuretic peptide (BNP) has become a potent diagnostic aid as a means of identifying patients with systolic or diastolic dysfunction. Due to better stability in circulating blood, we reasoned that measurement of N-terminal proBNP (NT-proBNP) may be a more discerning marker for the detection and evaluation of chronic heart failure.
The relationships between plasma concentrations of NT-proBNP and BNP, and aetiology, New York Heart Association (NYHA) classification, and left ventricular ejection fraction (LVEF) were analyzed in 105 patients with chronic heart failure. Sixty-seven healthy volunteers were studied as the controls.
Both NT-proBNP and BNP showed progressive increases (P<0.001) in proportion to the NYHA classification; the increment of NT-proBNP was larger than that of BNP. Elevated NT-proBNP significantly correlated with BNP (r=0.737, P<0.001). Receiver operating characteristics analysis to detect LVEF<40% showed similar values (area under the curve, AUC: NT-proBNP 0.754 vs. BNP 0.770), however, AUC to detect LVEF<50% tended to be greater for NT-proBNP than that for BNP (NT-proBNP 0.820 vs. BNP 0.794).
NT-proBNP may be a more discerning marker for the detection and evaluation of heart failure than BNP.
脑钠肽(BNP)检测已成为一种有效的诊断辅助手段,用于识别收缩或舒张功能障碍患者。鉴于其在循环血液中具有更好的稳定性,我们推断N末端脑钠肽前体(NT-proBNP)检测可能是检测和评估慢性心力衰竭更具鉴别力的标志物。
分析了105例慢性心力衰竭患者血浆NT-proBNP和BNP浓度与病因、纽约心脏协会(NYHA)分级及左心室射血分数(LVEF)之间的关系。选取67名健康志愿者作为对照进行研究。
NT-proBNP和BNP均随NYHA分级呈逐渐升高趋势(P<0.001);NT-proBNP的升高幅度大于BNP。NT-proBNP升高与BNP显著相关(r=0.737,P<0.001)。检测LVEF<40%的受试者工作特征分析显示二者曲线下面积(AUC)值相近(NT-proBNP为0.754,BNP为0.770),然而,检测LVEF<50%时,NT-proBNP的AUC往往大于BNP(NT-proBNP为0.820,BNP为0.794)。
与BNP相比,NT-proBNP可能是检测和评估心力衰竭更具鉴别力的标志物。